Deep cultivation and anchor growth| Zhejiang Yi is deploying medium-and long-term core strategic pla-Zhejiang Zhongzai Medical Technology Co., Ltd

Deep cultivation and anchor growth| Zhejiang Yi is deploying medium-and long-term core strategic pla

Source：Zhongzai Release：2026-07-11 Category：Company News Read：12 times

Information Summary： Zhejiang Yizai Medical Technology Co., Ltd.(Zhejiang Zhongzai Medical subsidiary) successfully held a strategic planning and implementation seminar.

Based on new opportunities for the development of the medical device industry and focusing on

innovation breakthroughs and steady growth, recently, Zhejiang Yizai Medical Technology Co., Ltd.

(Zhejiang Zhongzai Medical subsidiary) successfully held a strategic planning and implementation

seminar. This meeting clarified the core development blueprint for the next ten years, firmly established

the "three times better" exponential growth strategic goal, and comprehensively finalized all-dimensional

implementation measures such as business layout, compliance construction, market expansion, and

organizational innovation, laying a solid foundation for enterprise scale, high-quality and sustainable

development.

01 Unlock a new path to exponential growth

strategy seminar

The conference officially established the core strategic positioning: to build an

innovative enterprise focusing on home medical devices, medical beauty, first

aid and rehabilitation devices, and to build a solid industrial chain industrial

transformation platform integrating self-research, entrusted processing, global

registration and market sales. With the ten-year strategic goal of "three times

ten times better", the business segment has set up a stepped growth path from

ten million to ten billion, clearly demarcated phased development milestones,

and enabled the enterprise to grow with goals, rhythm and confidence. According to the strategic planning, 2024 is the key year for foundation

building, and 3 benchmark products with annual sales of more than 8 million

yuan have been built; it is expected that the sales volume will exceed 100

million yuan in 2028, completing the leap-forward breakthrough in the first

stage; the sales target of 1 billion yuan will be achieved by 2030, and the

company will steadily move towards the echelon of 10 billion enterprises. Accurately lock the three core business tracks and build a diversified

and high-barrier product matrix. Focusing on the field of medical beauty

skin care and rehabilitation physiotherapy, we will deeply cultivate innovative

non-invasive and smart home products, covering sub-scenarios such as muscle

relaxation and phototherapy rehabilitation; at the same time, we will launch

a home health OTC track to create a high-repurchase, fast-digestion health

product line: Forward-looking layout future health technology, deepen the

field of smart wearable devices, and build long-term technical competition

barriers.

on-site direct hit

02 Build a global supply chain system

strategy seminar

Compliance is the lifeline of medical device companies. This meeting emphasized

the core position of compliance and supply chain construction, and introduced a

global registration plan and standardized production system construction plan to

protect business going abroad and large-scale production. In terms of global compliance registration, the company implements a parallel

registration strategy at home and abroad, and plans to implement 35 registration

projects before 2028, covering Class II and Class III medical devices and

authoritative certifications such as FDA and CE. In 2027, we will complete

IS013485 and MDSAP dual-system certification, build a full-process and

standardized quality control system, and build strong barriers to global

operations. At the end of the production and supply chain, the company adopts

the R & D + production and processing model, deeply cultivates core

patented technologies, strictly controls system qualifications and production

quality, implements production piece-rate reform and post and responsibility

mechanism, comprehensively optimizes production efficiency and delivery

stability, and solves production and operation core problems.

on-site direct hit

03Activate new momentum for brand growth

strategy seminar

In order to match the strategic growth goals, the company has established

a trinity market strategy of branding, channel diversification, and internal

entrepreneurship to break the dilemma of low-price competition and build a

sustainable growth marketing system. In terms of brand building, we will build a global social media matrix, create

brand IP, strengthen brand value output, and enhance product premium

capabilities; in terms of channel expansion, we plan to develop 20 e-commerce

platforms within three years, and simultaneously deepen offline pharmacies,

medical institutions, and government and enterprises Cooperation and other

multi-dimensional scenarios to achieve full online and offline coverage.

The incentive mechanism is comprehensively reformed, the internal

entrepreneurial partner model is implemented, and the project income

distribution mechanism is supported to deeply bind employee income and

project profits, promote the transformation of employees from "workers" to "

operators", and maximize the activation of team innovation vitality.

on-site direct hit

04 Efficient implementation of digital empowerment

strategy seminar

Strategy implementation is based on organization. In response to pain points

such as inefficient team collaboration, redundant processes, and missing closed

loop projects, the company has comprehensively launched performance reform

and digital upgrades to comprehensively improve organizational efficiency. The performance system has been restructured and upgraded, and a

three-stage assessment system of "building base period-soaring period-nirvana

period" has been established to achieve strong linkage between KPIs and salary,

establish a special incentive library, and implement the distribution principle of

"more work, more gain, efficiency first". Digital construction focuses on reducing

costs and improving efficiency, implementing the "one-time entry, shared by all

employees" data governance model, simplifying redundant processes, promoting

the digitalization and AI of strategies, systems, processes, and forms across the

entire link, and breaking information silos. The company attaches great importance to the voices of employees,

establishes a clear decision-making mechanism and a closed-loop culture of

project review, and ensures the efficient implementation of every strategic

deployment and the orderly advancement of every project.

on-site direct hit

conclusion

strategy seminar

The convening of this strategic seminar has pointed out a clear direction and

consolidated the implementation path for the development of the company's

medical device business in the next ten years. In the future, the company

will take the core goal of "three times better" strategy, adhere to the original

intention of compliance, deepen product innovation, activate organizational

vitality, broaden market boundaries, steadily advance the implementation of

goals at all stages, and strive to create a benchmark for high-quality

development in the medical device industry!

on-site direct hit

400-0858-856

Deep cultivation and anchor growth| Zhejiang Yi is deploying medium-and long-term core strategic pla

Zhejiang Zhongzai Medical Technology Co., Ltd

PRODUCT

MESSAGE

DOWNLOAD